Australian Pancreatic Cancer Genome Initiative (APGI)

Australia

1 September 2020 - 31 August 2021

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Australian Pancreatic Cancer Genome Initiative (APGI) published between 1 September 2020 - 31 August 2021 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Research collaboration: Australian Pancreatic Cancer Genome Initiative (APGI) is a research collaboration whose article contributions are accrued to its participating partner institutions.

Note: Articles may be assigned to more than one subject area.

Count Share
1 0.09

Outputs by subject (Share)

Subject Count Share
Life Sciences 1 0.09

Top articles by Altmetric score in current window

Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition

Cancer Research

2021-07-01

1 September 2020 - 31 August 2021

International vs. domestic collaboration by Share

  • 70.88% Domestic
  • 29.12% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by Share (12 total)

  • Australian Pancreatic Cancer Genome Initiative (APGI), Australia
  • Domestic institution
  1. Lowy Cancer Research Centre, Australia (0.46)
    0.09
    0.38
  2. University of New South Wales (UNSW Sydney), Australia (0.44)
    0.09
    0.35
  3. Children's Cancer Institute Australia (CCIA), Australia (0.27)
    0.09
    0.19
  4. The Kinghorn Cancer Centre (TKCC), Australia (0.20)
    0.09
    0.11
  5. Garvan Institute of Medical Research, Australia (0.14)
    0.09
    0.06
  6. St Vincent's Health Australia, Australia (0.14)
    0.09
    0.06
  7. The University of Sydney (USYD), Australia (0.13)
    0.09
    0.05
  8. Ingham Institute, Australia (0.11)
    0.09
    0.03
  9. The University of Queensland (UQ), Australia (0.11)
    0.09
    0.03
  10. Prince of Wales Hospital, Australia (0.11)
    0.09
    0.02

Top 10 international collaborators by Share (8 total)

  • Australian Pancreatic Cancer Genome Initiative (APGI), Australia
  • Foreign institution
  1. Cancer Research UK (CRUK), United Kingdom (UK) (0.19)
    0.09
    0.10
  2. University of Glasgow, United Kingdom (UK) (0.13)
    0.09
    0.05
  3. Koç University (KU), Turkey (0.11)
    0.09
    0.03
  4. TU Dresden, Germany (0.11)
    0.09
    0.02
  5. University of Verona (UNIVR), Italy (0.11)
    0.09
    0.02
  6. Johns Hopkins Medicine (JHM), JHU, United States of America (USA) (0.11)
    0.09
    0.02
  7. Johns Hopkins Health System Corporation (JHHS), United States of America (USA) (0.10)
    0.09
    0.01
  8. Johns Hopkins University (JHU), United States of America (USA) (0.10)
    0.09
    0.01

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Australian Pancreatic Cancer Genome Initiative (APGI)

Participating institutions

Australian Pancreatic Cancer Genome Initiative (APGI) is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Creative Commons License

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Return to institution outputs

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER